Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer. Zhang Q, Cai XW, Feng W, Yu W, et al. BMC Cancer 2022;22:96.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang Q, Cai XW, Feng W, Yu W, et al. Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer. BMC Cancer 2022;22:96.
PMID: 35065627